Nyumbani › Uzito Kupita Kiasi › Indiana › Indianapolis
Majaribio ya kliniki ya Uzito Kupita Kiasi katika Indianapolis, IN
Masomo 13 ya Uzito Kupita Kiasi yanatafuta washiriki katika vituo vya Indianapolis na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.
Maandishi rasmi ya utafiti (Kiingereza)
Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
InaajiriHatua 3
- IU Health - Riley Physicians Endo-Diab, Indianapolis
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
InaajiriHatua 3
- Midwest Inst For Clin Res, Indianapolis
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
InaajiriHatua 3
- Midwest Inst For Clin Res, Indianapolis
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
InaajiriHatua 3
- Indiana University Health University Hospital, Indianapolis
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
InaajiriHatua 3
- Riley Hospital for Children, Indianapolis
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
InaajiriHatua 3
- Indiana University Health University Hospital, Indianapolis
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
InaajiriHatua 3
- DM Clinical Research - Indianapolis, Indianapolis
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
InaajiriHatua 3
- AURORA-1 Clinical Site, Indianapolis
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
InaajiriHatua 3
- AURORA-2 Clinical Site, Indianapolis
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
InaajiriHatua 2
- Investigators Research Group, Brownsburg · Mi 14 mbali
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
InaajiriHatua 4
- Dawes Fretzin Clinical Research Group, LLC, Indianapolis
- The Indiana Clinical Trials Center, PC, Plainfield · Mi 14 mbali
A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
InaajiriHatua 3
- Midwest Inst For Clin Res, Indianapolis
Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes
Inaajiri
- Indiana University, Indianapolis
Majaribio ya Uzito Kupita Kiasi katika miji mingine
- San Antonio, TXUtafiti 34
- Houston, TXUtafiti 33
- Chicago, ILUtafiti 28
- Orlando, FLUtafiti 27
- Las Vegas, NVUtafiti 23
- Miami, FLUtafiti 23
- Atlanta, GAUtafiti 20
- Dallas, TXUtafiti 20
- New York City, NYUtafiti 19
- Jacksonville, FLUtafiti 19
- Washington, DCUtafiti 19
- Austin, TXUtafiti 18
Masomo mengine katika Indianapolis
- Saratani ya Mapafu Isiyo na Selu NdogoUtafiti 32
- Saratani (aina zote)Utafiti 24
- Kushindwa kwa MoyoUtafiti 23
- Saratani ya MatitiUtafiti 20
- UnenepuUtafiti 20
- Saratani ya MetastasiUtafiti 19
- Kansari ya kolorektaliUtafiti 18
- Kansari ya MayaiUtafiti 17
- Saratan ya MapafuUtafiti 16
- Magonjwa ya Moyo na Mishipa ya DamuUtafiti 16
- Kisukari cha Aina ya 1Utafiti 14
- Saratani ya EndometrialUtafiti 14
Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.